Quantification of myocardial blood flow will reform the detection of CAD

Journal of Nuclear Cardiology, Jun 2009

Juhani Knuuti, Sami Kajander, Maija Mäki, Heikki Ukkonen

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs12350-009-9101-1.pdf

Quantification of myocardial blood flow will reform the detection of CAD

Juhani Knuuti 0 1 2 Sami Kajander 0 1 2 Maija Maki 0 1 2 Heikki Ukkonen 0 1 2 0 Knuuti et al Quantification of myocardial blood flow 1 Knuuti et al Quantification of myocardial blood flow 2 Knuuti et al Quantification of myocardial blood flow The detection of functional consequences of epicardial coronary artery disease (CAD) has established role in guiding the therapy of the disease.1 In addition, the assessment of impairment in microcirculatory reactivity has recently gained more interest. Estimates of myocardial perfusion contain independent prognostic information about future major cardiac events and perfusion assessment is also useful in the monitoring of the effectiveness of risk reduction strategies.1 The standard assessment of myocardial perfusion is based on its relative distribution. This approach has obvious limitations since the interpretation is based on the assumption that the best perfused region is normal and can be used as a reference. Using quantification this limitation can be avoided and using absolute parameters instead of relative ones is expected to provide benefits in several clinical scenarios. Despite the recognized potential, the clinical use of absolute quantification has remained scarce. Recently, several imaging techniques have been studied aiming for the quantitative measurement of perfusion. In addition nuclear imaging, magnetic resonance imaging, and echocardiography have been investigated and shown promising preliminary quantitative results.2,3 Currently, the most robust technique to quantify perfusion noninvasively in human heart is positron emission tomography (PET). However, although the use of PET in cardiac imaging is rapidly increasing, the image interpretation has still been chiefly based on relative distribution of perfusion.4 This review is aiming for brief summary of the current knowledge of quantification of myocardial perfusion for the detection of clinical CAD. The aim is to demonstrate the potential of quantification using several real clinical examples where the additional information gained from quantification has significant impact on the clinical findings. - There are two major determinants that define the potential of imaging technique for quantification of myocardial perfusion. The imaging device and its performance will define how accurate and robust is the measurement of the signal that need to be quantified. The other main factor is the nature of the tracer or the contrast agent. The detailed analysis of different imaging technologies and their performance is beyond the scope of this review. PET is by nature a quantitative technique and currently the most robust technique to measure perfusion noninvasively in human heart. PET allows very fast and effective imaging protocols with low radiation burden.5-8 Several tracers have been used for the measurement of myocardial perfusion with PET, in particular, 15O-water,9] 13N-ammonia,10 the potassium analog 82Rb.11 Recently also new 18Fluoride-labeled12,13 as well as 68Ga-labeled compounds have been tested.14 Currently, 15O-water and 13N-ammonia are the tracers most widely used for the quantification of myocardial perfusion with PET. Tracer kinetic models for quantification of perfusion have been successfully validated in animals against the radiolabeled microsphere method over a wide flow range for both tracers.9,10 Single-tissue compartment models for an inert freely diffusible tracer are used for calculation of MBF by use of 15O-water.9 For 13N-ammonia a three-compartment model taking into account the myocardial metabolic trapping and whole-body metabolism has been used for calculation of perfusion.10,15 Typically, the models also correct for the partial volume effect and spillover from the left ventricular chamber into the myocardial regions. These two tracers have been found to be equivalent for quantifying myocardial perfusion.16 There are, however, some obvious differences between these two tracers. 13N-ammonia is extracted from blood with an extraction fraction lower than 100% and the extraction is inversely related to the perfusion (Figure 1). When 15O-water is used, perfusion is estimated from the tracers washout from the myocardium, whereas with 13N-ammonia, perfusion is calculated from the tracers uptake by myocardium. The most important limitation of perfusion tracers as regard to quantification is the suboptimal myocardial extraction of the tracer. In addition to suboptimal extraction level, even more problematic phenomenon is that the extraction is reduced with increasing perfusion (Figure 1). When extraction fraction is reduced with increasing perfusion the uptake of tracer is not linear with perfusion and higher flows are underestimated. This must be corrected in the mathematical model by increasing the higher range perfusion values using specific equations. However, in the case the extraction is much blunted very high correction factors need to be used or the correction may become (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs12350-009-9101-1.pdf

Juhani Knuuti, Sami Kajander, Maija Mäki, Heikki Ukkonen. Quantification of myocardial blood flow will reform the detection of CAD, Journal of Nuclear Cardiology, 2009, pp. 497-506, Volume 16, Issue 4, DOI: 10.1007/s12350-009-9101-1